Shared decision making in cancer treatment: A Dutch national survey on patients' preferences and perceptions

Marieke M.T. Kuijpers; H (Haske) van Veenendaal; Vivian Engelen; Ella Visserman; Eveline A. Noteboom; Anne M. Stiggelbout; Anne M. May; Niek de Wit; Elsken van der Wall; Charles W. Helsper

doi:10.1111/ecc.13534

Shared decision making in cancer treatment: A Dutch national survey on patients' preferences and perceptions

Marieke M.T. Kuijpers, H (Haske) van Veenendaal, Vivian Engelen, Ella Visserman, Eveline A. Noteboom, Anne M. Stiggelbout, Anne M. May, Niek de Wit, Elsken van der Wall, Charles W. Helsper^*

^*Corresponding author for this work

Health Services Management & Organisation (HSMO)

Research output: Contribution to journal › Article › Academic › peer-review

22 Citations (Scopus)

168 Downloads (Pure)

Abstract

Objective: Shared decision making (SDM) for cancer treatment yields positive results. However, it appears that discussing essential topics for SDM is not fully integrated into treatment decision making yet. Therefore, we aim to explore to what extent discussion of therapy options, treatment consequences, and personal priorities is preferred and perceived by (former) cancer patients. Methods: An online questionnaire was distributed by the Dutch Federation of Cancer Patient Organisations among (former) cancer patients in 2018. Results: Among 3785 (former) cancer patients, 3254 patients (86%) had discussed treatments with their health care provider (HCP) and were included for analysis. Mean age was 62.1 ± 11.5; 55% were female. Discussing the option to choose no (further) treatment was rated by 2751 (84.5%) as very important (median score 9/10—IQR 8–10). Its occurrence was perceived by 28% (N = 899), and short- and long-term treatment consequences were discussed in 81% (N = 2626) and 53% (N = 1727), respectively. An unmet wish to discuss short- and long-term consequences was reported by 22% and 26%, respectively. Less than half of the (former) cancer patients perceived that personal priorities (44%) and future plans (34%) were discussed. Conclusion: In the perception of (former) cancer patients, several essential elements for effective SDM are insufficiently discussed during cancer treatment decision making.

Original language	English
Article number	e13534
Number of pages	11
Journal	European Journal of Cancer Care
Volume	31
Issue number	1
DOIs	https://doi.org/10.1111/ecc.13534
Publication status	E-pub ahead of print - 2 Nov 2021

Bibliographical note

Funding Information:
An unrestricted educational grant was provided by Danone Ecosystem Funds and in‐kind support was provided by the NFK to use their online questionnaire tool (“Doneer‐je‐ervaring”) for approaching cancer patients for the study and gather the data from respondents.

Publisher Copyright:
© 2021 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ecc.13534

ecc.13534Licence: CC BY-NC-ND

Cite this

Kuijpers, M. M. T., van Veenendaal, H., Engelen, V., Visserman, E., Noteboom, E. A., Stiggelbout, A. M., May, A. M., de Wit, N., van der Wall, E., & Helsper, C. W. (2021). Shared decision making in cancer treatment: A Dutch national survey on patients' preferences and perceptions. European Journal of Cancer Care, 31(1), Article e13534. Advance online publication. https://doi.org/10.1111/ecc.13534

@article{0b9bc3a266334b3d9967ce6891616111,

title = "Shared decision making in cancer treatment: A Dutch national survey on patients' preferences and perceptions",

abstract = "Objective: Shared decision making (SDM) for cancer treatment yields positive results. However, it appears that discussing essential topics for SDM is not fully integrated into treatment decision making yet. Therefore, we aim to explore to what extent discussion of therapy options, treatment consequences, and personal priorities is preferred and perceived by (former) cancer patients. Methods: An online questionnaire was distributed by the Dutch Federation of Cancer Patient Organisations among (former) cancer patients in 2018. Results: Among 3785 (former) cancer patients, 3254 patients (86%) had discussed treatments with their health care provider (HCP) and were included for analysis. Mean age was 62.1 ± 11.5; 55% were female. Discussing the option to choose no (further) treatment was rated by 2751 (84.5%) as very important (median score 9/10—IQR 8–10). Its occurrence was perceived by 28% (N = 899), and short- and long-term treatment consequences were discussed in 81% (N = 2626) and 53% (N = 1727), respectively. An unmet wish to discuss short- and long-term consequences was reported by 22% and 26%, respectively. Less than half of the (former) cancer patients perceived that personal priorities (44%) and future plans (34%) were discussed. Conclusion: In the perception of (former) cancer patients, several essential elements for effective SDM are insufficiently discussed during cancer treatment decision making.",

author = "Kuijpers, {Marieke M.T.} and {van Veenendaal}, {H (Haske)} and Vivian Engelen and Ella Visserman and Noteboom, {Eveline A.} and Stiggelbout, {Anne M.} and May, {Anne M.} and {de Wit}, Niek and {van der Wall}, Elsken and Helsper, {Charles W.}",

note = "Funding Information: An unrestricted educational grant was provided by Danone Ecosystem Funds and in‐kind support was provided by the NFK to use their online questionnaire tool (“Doneer‐je‐ervaring”) for approaching cancer patients for the study and gather the data from respondents. Publisher Copyright: {\textcopyright} 2021 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.",

year = "2021",

month = nov,

day = "2",

doi = "10.1111/ecc.13534",

language = "English",

volume = "31",

journal = "European Journal of Cancer Care",

issn = "0961-5423",

publisher = "John Wiley & Sons Ltd.",

number = "1",

}

TY - JOUR

T1 - Shared decision making in cancer treatment

T2 - A Dutch national survey on patients' preferences and perceptions

AU - Kuijpers, Marieke M.T.

AU - van Veenendaal, H (Haske)

AU - Engelen, Vivian

AU - Visserman, Ella

AU - Noteboom, Eveline A.

AU - Stiggelbout, Anne M.

AU - May, Anne M.

AU - de Wit, Niek

AU - van der Wall, Elsken

AU - Helsper, Charles W.

N1 - Funding Information: An unrestricted educational grant was provided by Danone Ecosystem Funds and in‐kind support was provided by the NFK to use their online questionnaire tool (“Doneer‐je‐ervaring”) for approaching cancer patients for the study and gather the data from respondents. Publisher Copyright: © 2021 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.

PY - 2021/11/2

Y1 - 2021/11/2

N2 - Objective: Shared decision making (SDM) for cancer treatment yields positive results. However, it appears that discussing essential topics for SDM is not fully integrated into treatment decision making yet. Therefore, we aim to explore to what extent discussion of therapy options, treatment consequences, and personal priorities is preferred and perceived by (former) cancer patients. Methods: An online questionnaire was distributed by the Dutch Federation of Cancer Patient Organisations among (former) cancer patients in 2018. Results: Among 3785 (former) cancer patients, 3254 patients (86%) had discussed treatments with their health care provider (HCP) and were included for analysis. Mean age was 62.1 ± 11.5; 55% were female. Discussing the option to choose no (further) treatment was rated by 2751 (84.5%) as very important (median score 9/10—IQR 8–10). Its occurrence was perceived by 28% (N = 899), and short- and long-term treatment consequences were discussed in 81% (N = 2626) and 53% (N = 1727), respectively. An unmet wish to discuss short- and long-term consequences was reported by 22% and 26%, respectively. Less than half of the (former) cancer patients perceived that personal priorities (44%) and future plans (34%) were discussed. Conclusion: In the perception of (former) cancer patients, several essential elements for effective SDM are insufficiently discussed during cancer treatment decision making.

AB - Objective: Shared decision making (SDM) for cancer treatment yields positive results. However, it appears that discussing essential topics for SDM is not fully integrated into treatment decision making yet. Therefore, we aim to explore to what extent discussion of therapy options, treatment consequences, and personal priorities is preferred and perceived by (former) cancer patients. Methods: An online questionnaire was distributed by the Dutch Federation of Cancer Patient Organisations among (former) cancer patients in 2018. Results: Among 3785 (former) cancer patients, 3254 patients (86%) had discussed treatments with their health care provider (HCP) and were included for analysis. Mean age was 62.1 ± 11.5; 55% were female. Discussing the option to choose no (further) treatment was rated by 2751 (84.5%) as very important (median score 9/10—IQR 8–10). Its occurrence was perceived by 28% (N = 899), and short- and long-term treatment consequences were discussed in 81% (N = 2626) and 53% (N = 1727), respectively. An unmet wish to discuss short- and long-term consequences was reported by 22% and 26%, respectively. Less than half of the (former) cancer patients perceived that personal priorities (44%) and future plans (34%) were discussed. Conclusion: In the perception of (former) cancer patients, several essential elements for effective SDM are insufficiently discussed during cancer treatment decision making.

UR - http://www.scopus.com/inward/record.url?scp=85118387440&partnerID=8YFLogxK

U2 - 10.1111/ecc.13534

DO - 10.1111/ecc.13534

M3 - Article

C2 - 34729832

AN - SCOPUS:85118387440

SN - 0961-5423

VL - 31

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

IS - 1

M1 - e13534

ER -

Shared decision making in cancer treatment: A Dutch national survey on patients' preferences and perceptions

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this